Educational research & price index · Independent Janoshik & MZ Biolabs COA verification
Guide|3 CitationsBlends & Stacks1 : 1 Ratio Blend / StackFemale-friendly

Wolverine Stack Protocol: Recovery Blend Guide

Also known as: Wolverine Stack, BPC-157 + TB-500 Blend (1:1), 5mg/5mg or 10mg/10mg Recovery Blend

Dose Range
250–500 mcgResearch range
0Typical research window: 250–500 mcg600 mcg

Studied in published research — not a medical recommendation. Primary protocol (1:1 Pre-Mixed Blend Protocol (5mg/5mg or 10mg/10mg Vial)): 250–500 mcg BPC-157 + 250–500 mcg TB-500, Once daily or split 250mcg/250mcg AM & PM.

Protocol at a Glance
How Often
Daily

Once daily or split 250mcg/250mcg AM & PM

A Typical Run
4–8 weeks

Research-reported range (no primary dosing study). With a 5mg/5mg vial + 2mL BAC water, 10 units (0.10mL) = 250mcg BPC-157 + 250mcg TB-500

How It's Taken
Vial

Subcutaneous injection

Evidence
Clinical Trials

Published peer-reviewed research & clinical protocols

Half-Life & 72-Hour Clearance Shape
Not established

No verified human half-life on file for this compound

0h18h36h54h72h
On Your SyringeU-100 Insulin Syringe

A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.

5 mg vial · 2 mL water · 0.3 mL syringe
Concentration: 2.5 mg in every mL (25 mcg per unit)
0u6u12u18u24u30u
Low end: 250 mcg10 units
High end: 500 mcg20 units

All U-100: 100 units = 1 mL. 20 doses in the vial at the low end (10 doses at the high end).

Track the doses you run

Save Wolverine Blend (BPC-157 + TB-500) to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.

Verified Peptide Vial Suppliers · Sorted by Real $/mg•Checked Nov 11, 2026

Wolverine Blend (BPC-157 + TB-500) supplier & $/mg comparison.

Source:
Max $/mg:
Sort:
Ascension Peptides50% OFF AUTO-APPLIED
Batch COAs (Kovera Labs, MZ Biolabs) on product page
US Domestic Vial
50% Off First Order Link
$45.00 net$90.00
20mg Lyophilized Vial
$2.25/mg$4.50/mg retail
Bulletproof BioLabs
ILS Laboratories HPLC COA COA-2026-UJXWQD / COA-2026-Z4JXC2, lot BPB-2610-001
US Domestic Vial
Vendor-supplied list price (Nov 7, 2026; store requires login)
$95.00
20mg BPC-157 / TB-500 10/10mg blend
$4.75/mg
Elite Research USA
Batch COA on product page
US Domestic Vial
List price
$105.00
20mg vial
$5.25/mg
Direct Peptides
COA per store product page
US Domestic Vial
List price (last verified Nov 4, 2026; store now requires sign-in)
$109.00
20mg BPC-157 + TB-500 blend
$5.45/mg
Polaris Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$110.00
20mg TB-500 / BPC-157 10/10mg blend
$5.50/mg
Swift Peptides
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$131.99
20mg BPC-157 + TB-500 10/10mg
$6.60/mg
Core Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$195.00
20mg vial
$9.75/mg
Biotech Peptides
COA per store product page
US Domestic Vial
List price (verified Oct 31)
$115.00
10mg vial
$11.50/mg
BioLongevity Labs
COA per store product page
US Domestic Vial
List price (verified Nov 11, 2026)
$119.97
10mg BPC-157 + TB-500 blend
$12.00/mg
Sorted strictly by calculated $/mg or 2026 COA score. Only research peptide vial suppliers are included in $/mg benchmarks.
Full Verified $/mg Index →

At a Glance · 2026 FDA / 503A / WADA / Evidence Profile

2026 FDA 503A Cat-2 UpdateTier 3 — Translational Animal & Clinical Obs
Pharmacological Class
Multi-Peptide Synergistic Complex / Fixed-Ratio Research Stack
Administration Route
Under-the-skin injection (Subcutaneous injection)
2026 FDA & 503A Status
Not FDA-approved. In April 2026, the FDA removed 14 peptides (including BPC-157, Thymosin Beta-4/TB-500, CJC-1295, Ipamorelin, AOD-9604, Semax, Selank, and DSIP) from the Category 2 503A Interim Bulks List pending formal July 2026 PCAC rulemaking. Available as COA-verified research reference standards or via specialized physician telehealth guidance.
WADA Sport Status
Strictly Prohibited at All Times — WADA Section S2.2 (Peptide Hormones, Growth Factors, GH Fragments, BPC-157 & Thymosin-β4)
Evidence Tier
Tier 3 — Translational Animal & Clinical Obs: Replicated mammalian preclinical models plus extensive off-label physician & community protocol tracking

Bottom Line Up Front

The Wolverine Stack pairs BPC-157 (pentadecapeptide) with TB-500 (Thymosin Beta-4 fragment). Pre-mixed vials almost universally use a 1:1 ratio (5mg/5mg or 10mg/10mg dosed at 250–500 mcg each daily), whereas separate-vial protocols often run a 1:2.5 weekly ratio (500 mcg/day BPC-157 + 2.5 mg TB-500 twice weekly) to match each peptide's natural half-life.

Best evidence for

Published preclinical & translational clinical protocols

Weakest evidence for

Large multi-year outcomes in healthy non-clinical cohorts

Pharma equivalent

None

Studies on file

3 (1 human)

EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Wolverine Blend (BPC-157 + TB-500) is not FDA approved for human use (unless specified above). This information does not constitute medical advice.

Overview

The Wolverine Blend (BPC-157 + TB-500) is the gold-standard regenerative combination in orthopedic, athletic, and post-surgical recovery research. BPC-157 acts locally and enterically by upregulating growth hormone receptors on tendon fibroblasts and stimulating nitric-oxide/VEGFR2 angiogenesis, while TB-500 acts systemically by sequestering G-actin to drive endothelial and myoblast cell migration across injured tissue.

Mechanisms of Action

  • BPC-157 activates the FAK-paxillin pathway and upregulates growth hormone receptor expression on tendon/ligament fibroblasts
  • TB-500 (Thymosin Beta-4) binds G-actin to promote cell migration, stem cell recruitment, and reduced scar-tissue fibrosis
  • Dual angiogenic synergy via VEGFR2 upregulation (BPC-157) and endothelial progenitor migration (TB-500)
  • Downregulates pro-inflammatory cytokines (TNF-alpha, IL-6) in acute soft-tissue and joint injuries

Common Ratios, Vial Formats & Dosing Breakdown

Researchers use different ratios depending on whether they reconstitute a pre-mixed vial or draw from separate single-compound vials.

Open in Blend Calculator
1 : 1 Ratio

1:1 Pre-Mixed Vial (Standard Vendor Blend)

Calculate draw units →
Vial / Stack Breakdown

5mg BPC-157 / 5mg TB-500 (10mg total) or 10mg / 10mg (20mg total)

Typical Dosing & Syringe Draw

250–500 mcg BPC-157 + 250–500 mcg TB-500 once or twice daily

Why this ratio: Most convenient single-pin option. Reconstituting a 5mg/5mg vial with 2.0 mL BAC water yields 250 mcg of each peptide per 10 units (0.10 mL).

1 : 2.5 Weekly Ratio (Split Schedule)

Separate-Vial Half-Life Protocol (Clinical/Athletic)

Calculate draw units →
Vial / Stack Breakdown

10mg BPC-157 vial + 10mg TB-500 vial (separate)

Typical Dosing & Syringe Draw

250–500 mcg BPC-157 daily + 2.0–2.5 mg TB-500 twice weekly

Why this ratio: Common protocol: daily BPC-157 with twice-weekly TB-500. Human half-lives for both are not established.

2 : 1 Ratio

2:1 BPC-Dominant Tendon & Gut Ratio

Vial / Stack Breakdown

10mg BPC-157 / 5mg TB-500 (15mg total)

Typical Dosing & Syringe Draw

500 mcg BPC-157 + 250 mcg TB-500 daily (split AM/PM)

Why this ratio: Used when prioritizing focal enthesopathy (golfer/tennis elbow, Achilles) or GI mucosal repair.

Research Protocols

Summaries of published research. For educational purposes only.

Protocol NameSourceDoseFrequencyDurationRouteEvidenceLinkSave
1:1 Pre-Mixed Blend Protocol (5mg/5mg or 10mg/10mg Vial)
reported protocol
250–500 mcg BPC-157 + 250–500 mcg TB-500Once daily or split 250mcg/250mcg AM & PM4–8 weeksSubcutaneous injectionanimal—
Separate-Vial Half-Life Optimized Protocol
reported protocol
250 mcg BPC-157 (2x/day) + 2.5 mg TB-500 (2x/week)BPC-157 daily; TB-500 Monday & Thursday6 weeksSubcutaneous injectionanimal—
Baseline & Mid-Cycle Biomarker Bloodwork Panel

Systemic Inflammation, Tissue Repair & Immune Biomarker Panel (Wolverine Blend (BPC-157 + TB-500))

Objective inflammatory, hematologic, and trace-mineral markers to quantify connective-tissue recovery, cytokine resolution, and organ safety.

Draw fasted morning labs at Baseline (Day 0) and Mid-Cycle (Week 6–8)

hs-CRP (High-Sensitivity C-Reactive Protein)

Day 0 + Wk 6–8

Why track at baseline: Quantifies baseline systemic IL-6/NF-κB inflammatory burden from tendon, joint, gut, or vascular injury.

Week 6–8 check: Target <1.0 mg/L (optimal <0.5 mg/L) by Week 6–8 as tissue inflammation resolves.

ESR (Sedimentation Rate) & Ferritin

Day 0 + Wk 6–8

Why track at baseline: Tracks chronic connective-tissue and autoimmune/mucosal inflammatory activity alongside iron stores.

Week 6–8 check: Downward trend in ESR confirming structural resolution rather than temporary analgesic masking.

CBC with Differential (WBC, Neutrophil/Lymphocyte Ratio)

Day 0 + Wk 6–8

Why track at baseline: Evaluates innate/adaptive immune balance (especially for Thymosin Alpha-1, Thymosin Beta-4, LL-37 & KPV).

Week 6–8 check: Balanced lymphocyte count and improved Neutrophil-to-Lymphocyte Ratio (NLR 1.2–2.0).

CMP (Liver/Kidney) + Serum Copper & Zinc Ratio

Day 0 + Wk 6–8

Why track at baseline: Verifies baseline hepatic/renal function and checks Copper:Zinc balance before GHK-Cu / GLOW / KLOW protocols.

Week 6–8 check: Maintain 1:1 to 1.2:1 Zinc-to-Copper equilibrium and normal transaminases/creatinine.

Test before and during your protocol: one baseline panel of 100+ Quest biomarkers covering the markers above, plus a mid-cycle retest. No doctor visit required.Code SPAMBASSADOR
Get baseline bloodwork at Superpower

Related Studies

1 Human

Based on individual peptide research for BPC-157, TB-500, and Thymosin Alpha-1

Limitations: No clinical trials on this specific blend

2025|N/A
PubMed

Community Outcomes

Community Data Coming Soon

Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!

Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.

Important Warnings

  • •Both BPC-157 and TB-500 are prohibited at all times under the WADA S0/S2 list for tested athletes
  • •Theoretical angiogenic caution in individuals with active neoplasms
  • •Research use only — not FDA-approved
Sourcing, Diagnostic Bloodwork & Telehealth Pathways

Where to get Wolverine Blend (BPC-157 + TB-500), baseline labs & clinician oversight.

Full Wolverine Blend (BPC-157 + TB-500) $/mg comparison →
50% OFF AUTO-APPLIED$2.25/mg net

Ascension Peptides (US Vials)

MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.

MZ Biolabs COA (Grade A)Claim 50% Off
Verified Vial SuppliersGrade A COA

SwissChems & Limitless Biotech

Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).

LABS & 503A CLINICS$199/yr Labs · Rx Consult

Superpower Labs & 503A Telehealth

Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.

Code:SPAMBASSADOR

Where to buy Wolverine Blend (BPC-157 + TB-500): best verified price

Prices checked Nov 11, 2026 · sorted by $/mg · RUO

  1. 1. Ascension Peptides — $2.25/mg (20mg Lyophilized Vial, $45.00)
  2. 2. Bulletproof BioLabs — $4.75/mg (20mg BPC-157 / TB-500 10/10mg blend, $95.00)
  3. 3. Elite Research USA — $5.25/mg (20mg vial, $105.00)

Where is the cheapest place to buy Wolverine Blend (BPC-157 + TB-500)?

As of Nov 11, 2026, the lowest verified US domestic single-vial price we found is Ascension Peptides at $2.25/mg (20mg Lyophilized Vial, $45.00 after the 50% new-customer partner-link discount). We compared 9 US suppliers with live, checked prices.

How much does Wolverine Blend (BPC-157 + TB-500) cost per mg?

Verified US domestic prices currently range from $2.25/mg to $12.00/mg depending on supplier and vial size. Larger vials usually lower the $/mg.

How are these prices verified?

Each price is read from the supplier's own product page or store data and divided by the vial's mg. Suppliers we could not verify are left out rather than estimated. Tables sort strictly by $/mg, never by partner status. Prices are re-checked weekly on our price index.

Is Wolverine Blend (BPC-157 + TB-500) approved for human use?

Products from these suppliers are sold for laboratory research use only (RUO). This page is an educational price reference, not medical advice.

All compounds $/mgWeekly $/mg price indexReconstitution calculatorFree cheat sheet

FREE 1-PAGE PDF CHEAT SHEET

Peptide Reconstitution & U-100 Syringe Cheat Sheet

Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.

Unsubscribe anytime.Direct PDF Download

Vendor vs vendor: price per mg

Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.

Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →

Common questions

How many peptides are in the database?

100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.

Where can I compare peptide prices?

Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.